1.Simulation Analysis on the Compensation Mechanism for High-Quality Development of Public Hospitals Based on System Dynamics Model
Meifeng WANG ; Xiliang LENG ; Zhongyi TANG ; Haiyin WANG ; Botao TIAN ; Chunlin JIN
Chinese Health Economics 2025;44(11):14-21
Objective:To propose policy recommendations for the compensation mechanism of high-quality development of municipal public hospitals.Methods:Taking the municipal public hospitals in Shanghai as the research object,the aspects of financial subsidies,the structure of medical service income,investment in scientific research and education,and other social compensations were examined to conduct a systematic simulation of the operation of the average municipal public hospital in Shanghai under different policy intervention scenarios.Results:If the current conditions remain unchanged,the average municipal public hospital in Shanghai will face a deficit starting in 2032,the proportion of income from examinations and laboratory tests will surpass that of medical service income in 2026 and 2031,respectively.If the hospitals follow a plan of Combination Plan 3,4,and 5,the average municipal public hospital in Shanghai will be able to break even from 2023 to 2033,and the structure of medical service income will be significantly optimized.Conclusion:To establish a new compensation mechanism for high-quality hospital development that enhances medical services,it is recommended to optimize the structure of government financial compensation,explore rational pricing strategies based on categories,increase investment in scientific research and education while paying attention to the transformation of scientific and technological achievements,expand compensation channels for public hospitals,and improve relevant laws and regulations.
2.Clinical research report on Chinese patent medicines and classic traditional Chinese medicine prescriptions (2023)
Xiaolei WU ; Haiyin HU ; Yuetong WANG ; Fauci Alice Josephine ; Yazi ZHANG ; Wenting SONG ; Fengwen YANG ; Boli ZHANG ; Junhua ZHANG ; Zhaochen JI
Digital Chinese Medicine 2025;8(2):123-136
Objective:
Randomized controlled trials (RCTs) of Chinese patent medicines and classic traditional Chinese medicine prescriptions were systematically reviewed from both Chinese and English journals published in 2023. A preliminary summary and evaluation were conducted on the generation and translation of clinical evidence for these treatments. This analysis aims to inform future research on clinical efficacy evaluation and guide the rational application of evidence.
Methods:
RCTs of Chinese patent medicines and classic traditional Chinese prescriptions published in 2023 were comprehensively retrieved from the Artificial Intelligence Clinical Evidence Database for Chinese Patent Medicine (AICED-CPM), with supplementary searches conducted in China National Knowledge Infrastructure (CNKI), Wanfang Data, Chinese Science and Technology Journal Database (VIP), Chinese Biomedical Literature Database (SinoMed), Cochrane Library, PubMed, Embase, and Web of Science. The study characteristics and methodological quality of these RCTs were systematically analyzed and evaluated.
Results:
A total of 1 443 RCTs of Chinese patent medicines were included, comprising 1 399 Chinese articles and 44 English articles. Additionally, 334 RCTs of classic traditional Chinese medicine prescriptions were found, with 331 published in Chinese and 3 in English. 196 567 participants were included, covering 585 types of Chinese patent medicines (487 oral, 61 injectable, and 37 topical) and 179 classic traditional Chinese medicine prescriptions. The involved studies encompassed 22 types of diseases, with research primarily focusing on diseases of the circulatory system, the respiratory system, and the genitourinary system. The sample sizes ranged from 18 to 3 777 participants, and most studies were conducted at a single center. Methodologically, the implementation of allocation concealment and blinding remained insufficiently emphasized.
Conclusion
Overall, compared with 2022, both the number of RCT publications and their methodological quality have improved in 2023, with heightened attention to research on diseases of the genitourinary system. However, quality control and standardized management in the design and implementation processes still require enhancement to produce more high-quality clinical evidence and accelerate the translation and application of this evidence.
3.Exploration and practice of medical laboratory health economics
Jingfei LYU ; Jiayun LIU ; Haiyin WANG ; Xiaobing XIE ; Jiancheng XU ; Bing GU ; Yingchun XU
Chinese Journal of Laboratory Medicine 2025;48(4):453-458
The reliability and practicality of research findings in health economics are gradually becoming core issues of close concern for clinical and public health experts. As healthcare resources remain under increasing pressure, conducting efficient cost-effectiveness analyses and achieving rational resource allocation are becoming ever more critical. In recent years, medical laboratory health economics has transitioned from purely academic discussions to integration into clinical practice, becoming a key tool for improving the efficiency and quality of healthcare services. It has demonstrated remarkable results in optimizing patient management and medical decision-making processes. So we invited experts from the fields of medical laboratory science and health economics to share valuable experiences and unique insights on topics such as cost assessment methods, pricing strategies, quality regulation, and the role of medical laboratory health economics in enhancing clinical practice and patient benefits. These experts generally agree that, while research in medical laboratory health economics has shown significant advantages and effectively addressed urgent clinical needs in resource allocation and cost control, it still faces multiple challenges, including limitations in research methodology application, high operational costs, and insufficient standardization of management systems.
4.Predictive Models and Influencing Factors for the Work Relative Value Unit in Clinical Surgical Items Based on Generalized Linear Models and BP Neural Networks
Haiyin WANG ; Meifeng WANG ; Liang FANG ; Chunlin JIN
Chinese Health Economics 2025;44(4):61-64
Objective:In order to establish benchmark values for new medical service items,it aims to investigate the predictive models and influencing elements that affect the work relative value unit in clinical surgical items in China.Methods:Generalized Linear Model(GLM)and BP neural network techniques were used to investigate influencing factors and build prediction models using the National Medical Service Project Technical Specification(2023 Edition)as the value database.Results:The average relative value of human resource usage was 41.9,with a total of 6 011 items across 16 systems and anesthesia.The GLM's mean prediction error was 4%and its linear correlation coefficient was 0.997.The top 5 predictor variables in terms of importance were technical complexity(0.45),risk level(0.30),physician time(0.08),number of physicians(0.06),and nurse time(0.03).With a mean prediction error of 1.5%,the neural network model obtained a correlation coefficient of 0.996.Technical difficulty(0.20),physician time(0.20),perfusionist time(0.19),risk level(0.15),and medical technician time(0.06)were the top five predictors.Conclusion:Both types of predictive models are well-fitted and valid,and future medical service items can provide relative values of human resource consumption,creating an integrated relative point system.
5.Predictive Models and Influencing Factors for the Work Relative Value Unit in Clinical Surgical Items Based on Generalized Linear Models and BP Neural Networks
Haiyin WANG ; Meifeng WANG ; Liang FANG ; Chunlin JIN
Chinese Health Economics 2025;44(4):61-64
Objective:In order to establish benchmark values for new medical service items,it aims to investigate the predictive models and influencing elements that affect the work relative value unit in clinical surgical items in China.Methods:Generalized Linear Model(GLM)and BP neural network techniques were used to investigate influencing factors and build prediction models using the National Medical Service Project Technical Specification(2023 Edition)as the value database.Results:The average relative value of human resource usage was 41.9,with a total of 6 011 items across 16 systems and anesthesia.The GLM's mean prediction error was 4%and its linear correlation coefficient was 0.997.The top 5 predictor variables in terms of importance were technical complexity(0.45),risk level(0.30),physician time(0.08),number of physicians(0.06),and nurse time(0.03).With a mean prediction error of 1.5%,the neural network model obtained a correlation coefficient of 0.996.Technical difficulty(0.20),physician time(0.20),perfusionist time(0.19),risk level(0.15),and medical technician time(0.06)were the top five predictors.Conclusion:Both types of predictive models are well-fitted and valid,and future medical service items can provide relative values of human resource consumption,creating an integrated relative point system.
6.Simulation Analysis on the Compensation Mechanism for High-Quality Development of Public Hospitals Based on System Dynamics Model
Meifeng WANG ; Xiliang LENG ; Zhongyi TANG ; Haiyin WANG ; Botao TIAN ; Chunlin JIN
Chinese Health Economics 2025;44(11):14-21
Objective:To propose policy recommendations for the compensation mechanism of high-quality development of municipal public hospitals.Methods:Taking the municipal public hospitals in Shanghai as the research object,the aspects of financial subsidies,the structure of medical service income,investment in scientific research and education,and other social compensations were examined to conduct a systematic simulation of the operation of the average municipal public hospital in Shanghai under different policy intervention scenarios.Results:If the current conditions remain unchanged,the average municipal public hospital in Shanghai will face a deficit starting in 2032,the proportion of income from examinations and laboratory tests will surpass that of medical service income in 2026 and 2031,respectively.If the hospitals follow a plan of Combination Plan 3,4,and 5,the average municipal public hospital in Shanghai will be able to break even from 2023 to 2033,and the structure of medical service income will be significantly optimized.Conclusion:To establish a new compensation mechanism for high-quality hospital development that enhances medical services,it is recommended to optimize the structure of government financial compensation,explore rational pricing strategies based on categories,increase investment in scientific research and education while paying attention to the transformation of scientific and technological achievements,expand compensation channels for public hospitals,and improve relevant laws and regulations.
7.Exploration and practice of medical laboratory health economics
Jingfei LYU ; Jiayun LIU ; Haiyin WANG ; Xiaobing XIE ; Jiancheng XU ; Bing GU ; Yingchun XU
Chinese Journal of Laboratory Medicine 2025;48(4):453-458
The reliability and practicality of research findings in health economics are gradually becoming core issues of close concern for clinical and public health experts. As healthcare resources remain under increasing pressure, conducting efficient cost-effectiveness analyses and achieving rational resource allocation are becoming ever more critical. In recent years, medical laboratory health economics has transitioned from purely academic discussions to integration into clinical practice, becoming a key tool for improving the efficiency and quality of healthcare services. It has demonstrated remarkable results in optimizing patient management and medical decision-making processes. So we invited experts from the fields of medical laboratory science and health economics to share valuable experiences and unique insights on topics such as cost assessment methods, pricing strategies, quality regulation, and the role of medical laboratory health economics in enhancing clinical practice and patient benefits. These experts generally agree that, while research in medical laboratory health economics has shown significant advantages and effectively addressed urgent clinical needs in resource allocation and cost control, it still faces multiple challenges, including limitations in research methodology application, high operational costs, and insufficient standardization of management systems.
8.Research on Governance of Medical Service Price Coordination in the Yangtze River Delta Region from the Perspective of Social Network Analysis
Juan LI ; Liang FANG ; Haiyin WANG ; Chunlin JIN
Chinese Health Economics 2024;43(6):75-78
Objective:To explore the structural characteristics of the medical service price network in the Yangtze River Delta,and provide a new management perspective for the collaborative governance of medical service prices in the Yangtze River Delta.Methods:Taking the related medical security bureaus of some core cities in the Yangtze River Delta as samples,based on the social network analysis method,the structural characteristics of price linkage network are analyzed from the perspectives of network density and correlation,individual centrality and block model analysis.Results:Firstly,the price network is not tight and has poor stability;secondly,the price network is unbalanced,with the Municipal Medical Insurance Bureau playing different roles;thirdly,the price network has obvious spatial aggregation and spatial spillover.Conclusion:The overall situation of the medical service price linkage network is not optimistic,and the network advantages should be fully integrated to promote the coordinated development of medical service prices in the Yangtze River Delta Region.
9.International Practice and Insights on the Medical Insurance Access Mechanism of Medical Service Item Based on HTA
Chenxi ZHANG ; Haiyin WANG ; Xin LIU ; Chunlin JIN
Chinese Health Economics 2024;43(9):92-96
Objective:To discuss how to construct the medical insurance access for medical service items based on Health Tech-nology Assessment(HTA)applicable to China.Methods:This study consolidated the current medical insurance access in some prov-inces and cities from China and identified deficiencies through the expert interview.We summarized the experience and indicators contained in the HTA report in UK and Singapore by using literature analysis.Results:In most regions of China,the management of medical services price is gradually moving from exclusion items based on certain conditions to access approach,lacking of tools for assessment.In UK and Singapore,the medical insurance access mechanism mainly consists of subject selection,scoping,HTA imple-mentation and decision-making,in the HTA report,with the data including clinical evidence,cost evidence and budget impact on health system,etc.Conclusion:Building an evidence-based health policy decision-making framework through multi-criteria deci-sion analysis and the construction of medical insurance access mechanism based on HTA can be achieved by developing national guidelines,multi-scenario HTA systems,and enhancing the supervision on the process of HTA.
10.Progress of Theoretical and Empirical Research on ICER Thresholds in China and Its Enlightenment
Chenxi ZHANG ; Haiyin WANG ; Chunlin JIN
Chinese Health Economics 2024;43(11):32-34,40
Objective:To provide suggestions for exploring the ICER threshold's calculation method and reasonable estimation in China.Methods:It summarizes the consensus and analyze the disputes on thresholds in China based on theoretical and empirical research by literature review,compares the thresholds derived from willingness to pay versus opportunity cost methods.Results:Theoretical researches on threshold of China mainly focus on method for calculation,health output index,and health equity,etc.The controversy persists over the threshold's characteristics.The health care demand-side perspective willingness-to-pay method was the most widely used in the empirical studies,but the results of the thresholds measured by this method varied widely;the thresholds measured by the health care supply-side perspective opportunity cost method were lower than the thresholds obtained from the demand-side perspective.Conclusion:It is still essential to discuss the threshold's characteristics and establish the methods framework complementing both demand and supply side for Chinese health insurance,and to standardize and normalize the measurement methods,as well as to set up multi-level thresholds according to the preferences of the population,the severity of the disease,and so on,in order to take into account both economy and equity.

Result Analysis
Print
Save
E-mail